RedHill Biopharma Ltd.

RedHill Biopharma Ltd. - Enterprise Valueverified

RDHL

Price:

$0.67

Market Cap:

$2.11M

RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointestinal medications: Movantik, which addresses opioid-induced constipation in adults experiencing chronic non-cancer pain; Talicia, used to treat Helicobacter pylori infections in adult patients; and Aemcolo, prescribed for adults suffering from travelers' diarrhea. Its robust late-stage clinical pipeline features several promising investigational compounds. RHB-204 is currently in Phase 3 for pulmonary nontuberculous mycobacteria infections. Opaganib (Yeliva), an SK2 selective inhibitor, has comp...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2013-01-07

Stock Exchange

NASDAQ

Ticker

RDHL

The Enterprise Value as of August 2026 (TTM) for RedHill Biopharma Ltd. (RDHL) is -795286.00

According to RedHill Biopharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -795286.00. This represents a change of 1.58% compared to the average of -47297.70 of the last 4 quarters.

RedHill Biopharma Ltd. (RDHL) Historical Enterprise Value (quarterly & annually)

How has RDHL Enterprise Value performed in the past?

The mean historical Enterprise Value of RedHill Biopharma Ltd. over the last ten years is 203.33M. The current -795286.00 Enterprise Value has changed -139.11% with respect to the historical average. Over the past ten years (40 quarters), RDHL's Enterprise Value was at its highest in in the September 2020 quarter at 821.88M. The Enterprise Value was at its lowest in in the December 2025 quarter at -2901000.00.

Quarterly (TTM)
Annual

Average

203.33M

Median

189.88M

Minimum

352.95K

Maximum

646.27M

RedHill Biopharma Ltd. (RDHL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RedHill Biopharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.77%

Maximum Annual Enterprise Value = 646.27M

Minimum Annual Increase = -96.80%

Minimum Annual Enterprise Value = 352.95K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025352.95K-96.80%
202411.04M-23.94%
202314.52M-87.91%
2022120.10M-59.75%
2021298.42M-53.82%
2020646.27M92.77%
2019335.25M47.28%
2018227.63M38.20%
2017164.71M-23.41%
2016215.06M-18.52%

RedHill Biopharma Ltd. (RDHL) Average Enterprise Value

How has RDHL Enterprise Value performed in the past?

The current Enterprise Value of RedHill Biopharma Ltd. (RDHL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.64M

5-year avg

88.89M

10-year avg

203.33M

RedHill Biopharma Ltd. (RDHL) Enterprise Value vs. Peers

How is RDHL’s Enterprise Value compared to its peers?

RedHill Biopharma Ltd.’s Enterprise Value is less than IM Cannabis Corp. (32.03M), greater than Bio Green Med Solution, Inc. (-1067422.00), less than CNS Pharmaceuticals, Inc. (384.21K), less than Akanda Corp. (13.90M), less than BNB Plus Corp. (-738599.00), less than MSP Recovery, Inc. (759.66M), less than Flora Growth Corp. (1.74M), greater than GlucoTrack, Inc. (-3605086.00), less than Jaguar Health, Inc. (36.57M), greater than 60 Degrees Pharmaceuticals, Inc. (-2201800.00),

CompanyEnterprise ValueMarket cap
32.03M$385.68K
-1067422.00$2.27M
384.21K$3.10M
13.90M$162.80K
-738599.00$210.49K
759.66M$1.38K
1.74M$4.23M
-3605086.00$297.91K
36.57M$70.31K
-2201800.00$983.99K

Build a custom stock screener for RedHill Biopharma Ltd. (RDHL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RedHill Biopharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RedHill Biopharma Ltd. (RDHL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RedHill Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is RedHill Biopharma Ltd.'s Enterprise Value?

What is the highest Enterprise Value for RedHill Biopharma Ltd. (RDHL)?

What is the 3-year average Enterprise Value for RedHill Biopharma Ltd. (RDHL)?

What is the 5-year average Enterprise Value for RedHill Biopharma Ltd. (RDHL)?

How does the current Enterprise Value for RedHill Biopharma Ltd. (RDHL) compare to its historical average?